insights_auto
Why is GOVX down 9.15%?
Dive Deeperchevron_right
GOVX:NASDAQ
Geovax Labs Inc
$0.24
arrow_downward
-9.15%(-0.024) 1D
$0.25
arrow_upward
+3.11% (+0.0075)bedtimeAfter hours
Closed: Oct 14, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.28
High
$0.28
Low
$0.24
Mkt. cap
2.16M
Avg. vol.
718.43K
Volume
717.62K
52-wk high
$15.75
52-wk low
$0.24
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
Open
$0.28
High
$0.28
Low
$0.24
Mkt. cap
2.16M
Avg. vol.
718.43K
Volume
717.62K
52-wk high
$15.75
52-wk low
$0.24
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
Stock Titan
·
58 minutes ago
West Coast Community Bank ranked No. 12 among the top 25 publicly traded banks.
Yahoo Finance
·
31 minutes ago
Invesco QQQ Doesn't Own a Single Bank, and That's Not the Only Thing the Nasdaq-100 Leaves Out
Simply Wall Street
·
26 minutes ago
Lumentum Is Up 472% Even As It Swung To A Loss
Bloomberg.com
·
3 hours ago
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com